ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Divergent Molecular Pathways Underlie the Evolution of Allograft Fibrosis in Two Mouse Models of Chronic Lung Allograft Dysfunction

T. Watanabe, J. Allen, K. Boonstra, Z. Guan, K. Bei, S. Keshavjee, J. Yeung, T. Martinu, S. Juvet

Latner Thoracic Surgery Research Laboratories, Toronto Lung Transplant Program / University Health Network, Toronto, ON, Canada

Meeting: 2020 American Transplant Congress

Abstract number: 82

Keywords: Fibrosis, Lung transplantation

Session Information

Session Name: From Bench to Community to Bedside in Lung Transplantation

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:15pm-3:27pm

Location: Virtual

*Purpose: Chronic lung allograft dysfunction (CLAD) after lung transplantation (LTx) is potentiated by activation of the innate immune system and occurs in two patterns: diffuse pleuroparenchymal fibroelastosis (PPFE) and an airway-centered pathology, obliterative bronchiolitis (OB). Using a minor alloantigen-mismatched (C57BL/10 to C57BL/6) mouse LTx model, we have developed a model of PPFE-predominant fibrosis driven by ischemia-reperfusion injury (IRI) and a model of OB-predominant fibrosis driven by repeated airway instillation of lipopolysaccharide (LPS) (Figure A). We tested the hypothesis that the immune, inflammatory, and tissue remodelling pathways leading to these two phenotypes would differ and might reveal novel therapeutic targets.

*Methods: At days 14, RNA was extracted from mouse lung grafts and subjected to mRNA sequencing. To discern the contributions of the distinct innate stimuli (LPS and IRI) and the presence or absence of alloantigens (Syn- or Allografts), different groups of grafts (n=3-6 per group at each time point) were included: allografts with prolonged storage to induce IRI (AlloLong), allografts with minimal storage (AlloMin), syngrafts with prolonged storage (SynLong), allografts exposed to LPS (AlloLPS), allografts exposed to PBS (AlloPBS), and syngrafts exposed to LPS (SynLPS). RNAseq DESeq2 was used to perform differential discovery on the data, with the primary comparison being AlloLong versus AlloLPS. Pathway analysis was performed using the GO database.

*Results: The groups separated distinctly along two principal components in multidimensional space (Figure B). Analysis of differential gene expression indicated that AlloLPS grafts were enriched for neutrophil, monocyte and T cell signaling-related transcripts while AlloLong grafts were enriched for extracellular matrix remodelling, B cell and humoral immunity-related transcripts (Figure C). The observation of B cell transcripts in AlloLong grafts is consistent with our recent finding that fibrosis in this model is B cell dependent, and that the grafts contain tertiary lymphoid organs and extensive fibrosis resembling PPFE. AlloLPS grafts exhibit increased neutrophils and Th17 cells by flow cytometry and airway-centered OB-like lesions histologically.

*Conclusions: Our data suggest that the different patterns of CLAD pathology may be driven by distinct immune and tissue remodelling pathways.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Watanabe T, Allen J, Boonstra K, Guan Z, Bei K, Keshavjee S, Yeung J, Martinu T, Juvet S. Divergent Molecular Pathways Underlie the Evolution of Allograft Fibrosis in Two Mouse Models of Chronic Lung Allograft Dysfunction [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/divergent-molecular-pathways-underlie-the-evolution-of-allograft-fibrosis-in-two-mouse-models-of-chronic-lung-allograft-dysfunction/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences